NORTHERN TRUST CORP - SANA BIOTECHNOLOGY INC ownership

SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 119 filers reported holding SANA BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 7.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of SANA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$3,222,189
-33.7%
832,607
+2.1%
0.00%0.0%
Q2 2023$4,861,566
+95.0%
815,699
+7.0%
0.00%
Q1 2023$2,493,048
-19.2%
762,400
-2.3%
0.00%
-100.0%
Q4 2022$3,083,552
-35.0%
780,646
-1.2%
0.00%0.0%
Q3 2022$4,744,000
-7.0%
790,515
-0.4%
0.00%0.0%
Q2 2022$5,103,000
-18.5%
793,675
+4.7%
0.00%0.0%
Q1 2022$6,263,000
-49.1%
758,296
-4.5%
0.00%
-50.0%
Q4 2021$12,293,000
-30.6%
794,187
+1.0%
0.00%
-33.3%
Q3 2021$17,703,000
+209.1%
786,118
+169.8%
0.00%
+200.0%
Q2 2021$5,727,000
+4.2%
291,329
+77.4%
0.00%0.0%
Q1 2021$5,495,000164,1810.00%
Other shareholders
SANA BIOTECHNOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 34,239,018$673,139,0008.60%
Trustees of Columbia University in the City of New York 281,250$5,530,0008.17%
Crestline Management, LP 3,210,937$63,127,0005.44%
Omega Fund Management, LLC 843,750$16,588,0001.88%
Alphabet Inc. 2,812,500$55,294,0001.13%
SB Management Ltd 2,625,153$51,611,0000.61%
PUBLIC SECTOR PENSION INVESTMENT BOARD 4,508,111$88,629,0000.53%
HARVARD MANAGEMENT CO INC 468,749$9,216,0000.53%
Avidity Partners Management LP 778,597$15,307,0000.41%
Dragoneer Investment Group 1,500,000$29,490,0000.38%
View complete list of SANA BIOTECHNOLOGY INC shareholders